During the corresponding time, Halozyme Therapeutics Inc recorded a revenue increase by 47.67 % year on year, sequentially revenue grew by 27.68 %. While revenue at the Halozyme Therapeutics Inc 's corporate clients
Halozyme Therapeutics Inc's Comment on Sales, Marketing and Customers
The company sells Hylenex recombinant and XYOSTED in the U.S. to wholesale pharmaceutical distributors. Hylenex recombinant is distributed exclusively by Integrated Commercialization Solutions, a division of AmerisourceBergen Specialty Group, to hospitals. XYOSTED is distributed to retail pharmacies, the Veterans Administration, and other governmental agencies through wholesale distributors including Cardinal Health 105, Inc. (Specialty Pharmaceutical Services), McKesson Corporation, and Cencora Inc. (formerly AmerisourceBergen Corporation). Cardinal Health 105, Inc. and Knipper Health, Inc. provide logistics, warehousing, returns, inventory management, sales reporting, contract administration, chargebacks processing (Cardinal only), and accounts receivable management services. The company also contracts with specialty pharmacies for prescription fulfillment and utilizes third parties for regulatory monitoring and product maintenance. Customers and market segments include hospitals, retail pharmacies, the Veterans Administration, and other governmental agencies.
Halozyme Therapeutics Inc’s Comment on Sales, Marketing and Customers
The company sells Hylenex recombinant and XYOSTED in the U.S. to wholesale pharmaceutical distributors. Hylenex recombinant is distributed exclusively by Integrated Commercialization Solutions, a division of AmerisourceBergen Specialty Group, to hospitals. XYOSTED is distributed to retail pharmacies, the Veterans Administration, and other governmental agencies through wholesale distributors including Cardinal Health 105, Inc. (Specialty Pharmaceutical Services), McKesson Corporation, and Cencora Inc. (formerly AmerisourceBergen Corporation). Cardinal Health 105, Inc. and Knipper Health, Inc. provide logistics, warehousing, returns, inventory management, sales reporting, contract administration, chargebacks processing (Cardinal only), and accounts receivable management services. The company also contracts with specialty pharmacies for prescription fulfillment and utilizes third parties for regulatory monitoring and product maintenance. Customers and market segments include hospitals, retail pharmacies, the Veterans Administration, and other governmental agencies.
Sources:
Halozyme Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Halozyme Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Halozyme Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
114.01 %